Table 2.
Therapeutic effect data of HIFU treatment.
| Total | Stage III | Stage IV | p Value | |
|---|---|---|---|---|
| Mean tumor size; before therapy | 33.3 (±10.9) | 33.0 (±10.2) | 33.5 (±11.6) | p = 0.738 |
| after therapy | 33.5 (±11.3) | 33.5 (±11.3) | 34.0 (±12.2) | p = 0.790 |
| The rate of complete tumor ablation (%) | 90.3 | 92.1 | 88.5 | p = 0.469 |
| The rate of symptom relief effect (%) | 66.7 | 64.4 | 44.9 | p = 0.029 * |
| Rate of no worsening change of CA19-9 level (%) | 48.1 | 63.2 | 34.9 | p = 0.011 * |
| The effectiveness of primary lesion (CR/PR/SD/PD) | 0/21/106/49 | 0/12/60/17 | 0/9/46/32 | N/A |
| Primary disease control rate (DCR) (%) | 72.2 | 80.9 | 63.2 | p = 0.009 * |
| Therapy after HIFU (operation/chemotherapy/arterial infusion chemotherapy/ radiation/immunotherapy/BSC) |
8/149/1/0/4/22 | 7/74/0/0/1/12 | 1/75/1/0/3/10 | N/A |
* p < 0.05.